Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Evaluating process changes in a pediatric hospital medication system.

Barbara L Marino1, Patricia Branowicki, James A Bennett

  • 1PHT Corporation, Charlestown, Mass., USA. bmarino@phtcorp.com

Outcomes Management
|December 26, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metastatic Tumour Burden as Prognostic Factor in Nivolumab-Treated Metastatic Renal Cell Carcinoma: An Exploratory Study.

Current oncology (Toronto, Ont.)·2026
Same author

The Landscape of Prostate Tumour Methylation.

Cancer discovery·2026
Same author

High-confidence structural predictions of extrachromosomal DNA with ecDNAInspector.

bioRxiv : the preprint server for biology·2026
Same author

Dose-dense chemotherapy enables elimination of RT for the majority of low-risk pediatric Hodgkin lymphomas: PHC study HOD08.

Blood·2026
Same author

Proof-of-Concept Study of an Alpha-Fetoprotein-Derived Peptide for the Management of Canine Mammary Cancer.

Animals : an open access journal from MDPI·2023
Same author

Mainstreaming of genomics in oncology: a nationwide survey of the genomics training needs of UK oncologists.

Clinical medicine (London, England)·2023

A new multidisciplinary check (MDC) process significantly improved chemotherapy order safety for pediatric oncology patients. This collaborative review identified and corrected discrepancies, preventing potential medication errors.

Area of Science:

  • Pediatric Oncology
  • Medication Safety
  • Health Informatics

Background:

  • Complex chemotherapy order sets pose risks in pediatric oncology.
  • Effective communication and review are crucial for medication safety.
  • Existing processes may not adequately address order set complexity.

Purpose of the Study:

  • To evaluate a novel multidisciplinary check (MDC) process for chemotherapy orders.
  • To assess the impact of MDC on the safety of prescribing and interpreting complex order sets.
  • To determine the efficiency and feasibility of the MDC process.

Main Methods:

  • Review of 1792 chemotherapy orders for pediatric oncology patients (June 1998-February 2000).
  • Implementation and evaluation of a multidisciplinary check (MDC) forum for simultaneous review and modification of order sets.

Related Experiment Videos

  • Analysis of MDC completion rates and types of order changes, focusing on medication error prevention.

    • Main Results:

    • 96% of eligible chemotherapy orders underwent the multidisciplinary check.
    • 44% of reviewed orders were modified during the MDC process.
    • Discrepancies with protocols were the most common changes; 99 of 451 orders were changed to avoid medication errors, often involving non-chemotherapy drugs.

    Conclusions:

    • The multidisciplinary check (MDC) is an efficient and feasible process for enhancing medication safety.
    • Implementing MDC at the outset of the medication system improves the safety of complex chemotherapy orders.
    • Collaborative review by multiple disciplines effectively identifies and rectifies potential errors in pediatric oncology medication orders.